Functional analysis of LDLR variants reveals that the novel p.(Ser610Tyr) variant in the YMDD motif drastically impacts LDL uptake

Abstract

Background and AimsFamilial hypercholesterolemia (FH) is an inherited metabolic disease characterized by high low-density lipoprotein cholesterol (LDL-c) levels, leading to premature cardiovascular events. The heterozygous form (HeFH) affects 1 in 313 people, while the homozygous form (HoFH) affects 1 in 360,000. FH is primarily caused by pathogenic variants in the LDLR gene (79%), with other genes like APOB, PCSK9, and LDLRAP1 also involved. Functional studies are essential to determine the impact of these variants on protein function, aiding in accurate diagnosis and treatment. This study characterizes a new LDLR variant and analyzes several others in hypercholesterolemia patients. MethodsA newly detected variant, along with seven other LDLR variants initially classified as of uncertain significance, were selected from a cohort of hypercholesterolemic patients referred to our center for genetic analysis. Variant classification was performed according to ACMG/AMP guidelines. Functional studies included measuring LDL-Dil uptake, binding, and surface expression of the LDLR using flow cytometry. ResultsThe analyzed variants included the novel, LDLR: c.1829C>A p.(Ser610Tyr) and the following: c.115T>C p.(Cys39Arg), c.185C>T p.(Thr62Met), c.968G>T p.(Gly323Val), c.1156G>T p.(Asp386Tyr), c.1966C>T p.(His656Tyr), c.2101G>A p.(Gly701Ser), and c.2231G>A p.(Arg744Gln). Functional studies reclassified five of these variants as probably pathogenic or pathogenic. ConclusionsFunctional studies of LDLR variants are essential to demonstrate disease causality in FH. Early diagnosis and appropriate treatment can significantly reduce coronary artery disease, highlighting the importance of demonstrating the impact of LDLR variants.